Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration

Paola Sgadò, Cristina Viaggi, Annalisa Pinna, Cristina Marrone, Francesca Vaglini, Silvia Pontis, Nicola Biagio Mercuri, Micaela Morelli, Giovanni Umberto Corsini

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In idiopathic Parkinson's disease, clinical symptoms do not emerge until consistent neurodegeneration has occurred. The late appearance of symptoms implies the existence of a relatively long preclinical period during which several disease-induced neurochemical changes take place to mask the existence of the disease and delay its clinical manifestations. The aim of this study was to examine the neurochemical, neurophysiological, and behavioral changes induced by the loss of nigrostriatal innervation in the En1+/-;En2-/- mouse, in the 10 months following degeneration, compared to En2 null mutant mice. Behavioral analysis (Pole-test, Beam-walking test, and Inverted grid test) and field potential recordings in the striatum indicated that loss of ∼70% of nigrostriatal neurons produced no significant functional effects until 8 months of age, when En1+/-;En2-/- animals started to show frank motor deficits and electrophysiological alterations in corticostriatal plasticity. Similarly, alterations in dopamine homeostasis, dopamine turnover, and dopamine innervation were observed in aged animals compared to young En1+/-;En2-/- mice. These data suggests that in En1+/-;En2-/- mice nigrostriatal degeneration in the substantia nigra is functionally compensated.

Original languageEnglish
Pages (from-to)170-181
Number of pages12
JournalNeurotoxicity Research
Volume20
Issue number2
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Dopamine
Animals
Neurons
Plasticity
Masks
Poles
Substantia Nigra
Walking
Parkinson Disease
Homeostasis

Keywords

  • Dopamine transporter
  • Engrailed
  • Parkinson's disease
  • Presymptomatic compensation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration. / Sgadò, Paola; Viaggi, Cristina; Pinna, Annalisa; Marrone, Cristina; Vaglini, Francesca; Pontis, Silvia; Mercuri, Nicola Biagio; Morelli, Micaela; Corsini, Giovanni Umberto.

In: Neurotoxicity Research, Vol. 20, No. 2, 08.2011, p. 170-181.

Research output: Contribution to journalArticle

Sgadò, Paola ; Viaggi, Cristina ; Pinna, Annalisa ; Marrone, Cristina ; Vaglini, Francesca ; Pontis, Silvia ; Mercuri, Nicola Biagio ; Morelli, Micaela ; Corsini, Giovanni Umberto. / Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration. In: Neurotoxicity Research. 2011 ; Vol. 20, No. 2. pp. 170-181.
@article{1f5f9aba786a4755a5156126d5a06b28,
title = "Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration",
abstract = "In idiopathic Parkinson's disease, clinical symptoms do not emerge until consistent neurodegeneration has occurred. The late appearance of symptoms implies the existence of a relatively long preclinical period during which several disease-induced neurochemical changes take place to mask the existence of the disease and delay its clinical manifestations. The aim of this study was to examine the neurochemical, neurophysiological, and behavioral changes induced by the loss of nigrostriatal innervation in the En1+/-;En2-/- mouse, in the 10 months following degeneration, compared to En2 null mutant mice. Behavioral analysis (Pole-test, Beam-walking test, and Inverted grid test) and field potential recordings in the striatum indicated that loss of ∼70{\%} of nigrostriatal neurons produced no significant functional effects until 8 months of age, when En1+/-;En2-/- animals started to show frank motor deficits and electrophysiological alterations in corticostriatal plasticity. Similarly, alterations in dopamine homeostasis, dopamine turnover, and dopamine innervation were observed in aged animals compared to young En1+/-;En2-/- mice. These data suggests that in En1+/-;En2-/- mice nigrostriatal degeneration in the substantia nigra is functionally compensated.",
keywords = "Dopamine transporter, Engrailed, Parkinson's disease, Presymptomatic compensation",
author = "Paola Sgad{\`o} and Cristina Viaggi and Annalisa Pinna and Cristina Marrone and Francesca Vaglini and Silvia Pontis and Mercuri, {Nicola Biagio} and Micaela Morelli and Corsini, {Giovanni Umberto}",
year = "2011",
month = "8",
doi = "10.1007/s12640-010-9232-9",
language = "English",
volume = "20",
pages = "170--181",
journal = "Neurotoxicity Research",
issn = "1029-8428",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration

AU - Sgadò, Paola

AU - Viaggi, Cristina

AU - Pinna, Annalisa

AU - Marrone, Cristina

AU - Vaglini, Francesca

AU - Pontis, Silvia

AU - Mercuri, Nicola Biagio

AU - Morelli, Micaela

AU - Corsini, Giovanni Umberto

PY - 2011/8

Y1 - 2011/8

N2 - In idiopathic Parkinson's disease, clinical symptoms do not emerge until consistent neurodegeneration has occurred. The late appearance of symptoms implies the existence of a relatively long preclinical period during which several disease-induced neurochemical changes take place to mask the existence of the disease and delay its clinical manifestations. The aim of this study was to examine the neurochemical, neurophysiological, and behavioral changes induced by the loss of nigrostriatal innervation in the En1+/-;En2-/- mouse, in the 10 months following degeneration, compared to En2 null mutant mice. Behavioral analysis (Pole-test, Beam-walking test, and Inverted grid test) and field potential recordings in the striatum indicated that loss of ∼70% of nigrostriatal neurons produced no significant functional effects until 8 months of age, when En1+/-;En2-/- animals started to show frank motor deficits and electrophysiological alterations in corticostriatal plasticity. Similarly, alterations in dopamine homeostasis, dopamine turnover, and dopamine innervation were observed in aged animals compared to young En1+/-;En2-/- mice. These data suggests that in En1+/-;En2-/- mice nigrostriatal degeneration in the substantia nigra is functionally compensated.

AB - In idiopathic Parkinson's disease, clinical symptoms do not emerge until consistent neurodegeneration has occurred. The late appearance of symptoms implies the existence of a relatively long preclinical period during which several disease-induced neurochemical changes take place to mask the existence of the disease and delay its clinical manifestations. The aim of this study was to examine the neurochemical, neurophysiological, and behavioral changes induced by the loss of nigrostriatal innervation in the En1+/-;En2-/- mouse, in the 10 months following degeneration, compared to En2 null mutant mice. Behavioral analysis (Pole-test, Beam-walking test, and Inverted grid test) and field potential recordings in the striatum indicated that loss of ∼70% of nigrostriatal neurons produced no significant functional effects until 8 months of age, when En1+/-;En2-/- animals started to show frank motor deficits and electrophysiological alterations in corticostriatal plasticity. Similarly, alterations in dopamine homeostasis, dopamine turnover, and dopamine innervation were observed in aged animals compared to young En1+/-;En2-/- mice. These data suggests that in En1+/-;En2-/- mice nigrostriatal degeneration in the substantia nigra is functionally compensated.

KW - Dopamine transporter

KW - Engrailed

KW - Parkinson's disease

KW - Presymptomatic compensation

UR - http://www.scopus.com/inward/record.url?scp=80052634167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052634167&partnerID=8YFLogxK

U2 - 10.1007/s12640-010-9232-9

DO - 10.1007/s12640-010-9232-9

M3 - Article

C2 - 21104462

AN - SCOPUS:80052634167

VL - 20

SP - 170

EP - 181

JO - Neurotoxicity Research

JF - Neurotoxicity Research

SN - 1029-8428

IS - 2

ER -